Kestra Investment Management’s Boston Scientific BSX Stock Holding History

Kestra Investment Management’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-2,323	Closed	-$227K	–	436
2025 Q3	$227K	Buy	+2,323	New	+$241K	0.01%	398
2025 Q2	–	Sell	-108	Closed	-$10.9K	–	766
2025 Q1	$10.9K	Sell	108 -446	-81%	-$44.9K	﹤0.01%	616
2024 Q4	$49.5K	Buy	+554	New	+$48.8K	﹤0.01%	542

Other funds holding BSX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Kestra Investment Management's BSX Position: Q4 2025 in Review

Kestra Investment Management sold out of Boston Scientific (BSX) in Q4 2025, closing a stake of 2,323 shares — an estimated $227K sold.

Kestra Investment Management first reported a position in BSX in Q4 2024 and held it in 3 quarters. The position peaked at $227K in Q3 2025. 1,795 funds tracked by Wall St. Rank hold BSX as of Q4 2025.

Kestra Investment Management reported no remaining Boston Scientific position as of Q4 2025 after selling out during the quarter.
Kestra Investment Management sold 2,323 Boston Scientific shares in Q4 2025, an estimated $227K.
Kestra Investment Management first reported a position in Boston Scientific in Q4 2024 and held it in 3 quarters.
Kestra Investment Management's Boston Scientific position peaked at $227K in Q3 2025.
1,795 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2025.

Based on Kestra Investment Management's 13F filing for Q4 2025, filed 9 Feb 2026.